Clinical Trials

Portopulmonary hypertension

Displaying 2 studies

PORtopulmonary Hypertension Treatment WIth MaCitentan ─ A RandOmized Clinical Trial Scottsdale/Phoenix, AZ

24-week study to evaluate the efficacy and safety of macitentan for the treatment of portopulmonary hypertension.
A Study To Evaluate Pulmonary Vascular Complications Of Liver Disease 3 (PVCLD3) Rochester, MN

The purpose of this study is toexamine whether increased sphingosine 1 phosphate : ceramide ratio and circulating bile acids are associated with HPS in patients with advanced liver disease.